How do you treat a 35-year-old male with extensive hidradenitis suppurativa (HS) of the perianal skin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Extensive Perianal Hidradenitis Suppurativa

For a 35-year-old male with extensive hidradenitis suppurativa of the perianal region covering a 15x15cm area, surgical excision with healing by secondary intention is the most appropriate treatment approach. 1, 2

Disease Assessment

  • This case represents Hurley stage III (severe) disease based on the extensive involvement and likely presence of interconnected sinus tracts and scarring 1
  • Immediate referral to dermatology secondary care is indicated for Hurley stage III disease 1
  • Pain assessment using Visual Analog Scale (VAS) and quality of life measurement using Dermatology Life Quality Index (DLQI) should be performed 3

Initial Management

  • For perianal hidradenitis of this extent, immediate treatment with combination antibiotics is recommended:
    • Clindamycin 300 mg twice daily with rifampicin 300 mg twice daily for 10-12 weeks 1, 4
  • Pain management with NSAIDs should be initiated 1
  • Provide appropriate dressings for pus-producing lesions 1
  • Screen for depression/anxiety, which is common in HS patients 1
  • Screen for cardiovascular risk factors (BP, lipids, HbA1c) 1
  • Address modifiable risk factors:
    • Offer smoking cessation if applicable 1
    • Offer weight management if applicable 1, 4

Definitive Treatment

  • For extensive perianal hidradenitis (15x15cm), surgical referral to a hidradenitis suppurativa surgical multidisciplinary team is the definitive treatment 1
  • Wide surgical excision is the treatment of choice for extensive perianal disease 2, 5
  • Healing by secondary intention using tap water-moistened plain gauze dressings changed 2-3 times daily is a practical approach with good results 2
  • Expected healing time for large wounds left open for secondary intention is approximately 10-12 weeks 5, 6
  • Alternative wound management options include:
    • Partial closure of the wound 2
    • Delayed skin grafting, which may reduce healing time to approximately 6-8 weeks 5

Special Considerations for Perianal Disease

  • Diverting colostomy may be necessary in some cases (41% of patients in one study) to facilitate wound healing 5
  • Careful evaluation for malignancy is essential, as squamous cell carcinoma can develop in long-standing hidradenitis suppurativa 5, 6
  • Multidisciplinary team approach involving dermatology, colorectal surgery, and wound care specialists is crucial 6

Follow-up and Monitoring

  • Regular follow-up is essential to monitor wound healing and detect recurrence 2
  • Recurrence is common and should be anticipated as a feature of the disease rather than a failure of treatment 2
  • Long-term follow-up is necessary as some patients require multiple procedures over years to maintain control of symptoms 2, 6

Biologic Therapy Considerations

  • If surgery is contraindicated or patient declines, adalimumab (Humira) is FDA-approved for moderate to severe hidradenitis suppurativa 7
  • Dosing: 160 mg initially (Day 1), 80 mg two weeks later (Day 15), then 40 mg weekly starting at week 4 7
  • However, for extensive perianal disease of this magnitude, surgical intervention remains the definitive treatment 1, 2, 5

Pitfalls to Avoid

  • Inadequate excision is a common cause of recurrence; wide margins are essential 2, 5
  • Delayed surgical intervention can lead to complications including fistula formation, scarring, and rarely malignant transformation 5, 6
  • Antibiotics alone are unlikely to provide definitive treatment for extensive disease 6, 8
  • Patients must be followed until definitive healing, as inadequate follow-up can lead to recurrence 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hidradenitis Suppurativa Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hidradenitis Suppurativa Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of patients with hidradenitis suppurativa.

Actas dermo-sifiliograficas, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.